According to a bourse filing, Sanofi-Aventis Pakistan has reported that one of the company’s third-party operated warehouse has caught fire.
The company estimated the inventory loss resulting from the fire to exceed Rs. 56 million.
Sanofi-Aventis Pakistan Limited reported its earnings results for the third quarter and nine months, ended September 30 2017, recently. For the quarter, the company’s net sales were Rs. 3.13 billion compared to Rs. 3.73 billion a year ago.
Profit before taxation was Rs. 1.39 billion compared to Rs. 1.10 billion in the same period last year. Net profit was Rs. 947 million compared to Rs. 606 million last year.
Sanofi-Aventis Pakistan Limited manufactures and sells pharmaceutical and consumer products primarily in Pakistan.
The company provides its products in various therapeutic areas, including oral anti-diabetes, insulin, cancer, pain management, urology, allergy management, cough and cold, sleep disorders, emergency care, cardiology, antibiotics, emergency care, diarrhea, gastric diseases, epilepsy, anti-malaria, and consumer health care.
The company offers its products in oral solid and liquid dosage, and sterile product forms. It also provides a range of vaccines. It serves distributors, hospitals, and government institutions.